Presentation TCT 2023 TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year? Presenter: Michael Bashline October 26, 2023
Presentation TCT 2023 TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Presenter: Muhammad Junaid Ahsan October 26, 2023
News Conference News TCT 2023 ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation Todd Neale October 26, 2023
Presentation TCT 2023 TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device Presenter: Priyadarshini Dixit October 25, 2023
Presentation TCT 2023 Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study Presenter: Suzanne Arnold October 25, 2023
Presentation TCT 2023 TCT 621: Takotsubo Cardiomyopathy And Cardiogenic Shock: Outcomes Associated With The Use of Mechanical Circulatory Device Presenter: Tauseef Akhtar October 25, 2023
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
Presentation TCT 2023 TCT 983: Recurrent Takotsubo Cardiomyopathy associated with Chronic Pancreatitis Presenter: Yulith Roca Alvarez October 24, 2023
News Daily News Sham Procedures in CV Research: What’s Sacrificed for Science? Caitlin E. Cox October 23, 2023
News Conference News HFSA 2023 ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT Yael L. Maxwell October 16, 2023
News Conference News HFSA 2023 Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships Shelley Wood October 13, 2023
News Conference News HFSA 2023 PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization L.A. McKeown October 12, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Daily News FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy L.A. McKeown October 10, 2023
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
News Daily News Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort Yael L. Maxwell September 06, 2023
News Conference News ESC 2023 More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM Michael O'Riordan August 31, 2023